What is Wegovy and who is eligible?
What the papers say – May 14
Anti-obesity jab ‘cuts risk of heart attack or stroke regardless of weight lost’
Gradual weaning off anti-obesity jabs could help avoid weight gain – study
Growing demand for weight loss treatments drives sales at drugmaker Novo Nordisk
Doctors warn babies may be harmed by weight-loss drugs
What is Mounjaro?
Diabetes drug authorised for weight management and loss – MHRA
Urgent warning over counterfeit Ozempic after hospitalisations
Weight-loss jabs linked to ‘severe’ stomach problems – study
Weight loss jab ‘significantly’ improves blood sugar in diabetics, study finds
‘Semaglutide could eliminate need for insulin in new type 1 diabetes patients’
Wegovy weight-loss jab to launch in the UK
Weight loss jabs improve heart failure symptoms in obese patients
Weight loss jabs improve heart failure symptoms in obese patients – study
Virtual services recommended to tackle obesity crisis